Access Now: Equitymaster's Premium Small Cap Research at 50% Off
Here is the latest financial fact sheet of LYKA LABS. For more details, see the LYKA LABS quarterly results and LYKA LABS share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 8.8 |
No. of shares | m | 33.09 |
1 Week | % | 16.9 |
1 Month | % | 1.4 |
1 Year | % | -15.5 |
52 week H/L | Rs | 165.0/89.0 |
No. of Mths Year Ending |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
5-Yr Chart Click to enlarge
|
---|
LYKA LABS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 82 | 52 | 35 | 36 | 267 | |
Low | Rs | 39 | 21 | 10 | 13 | 25 | |
Sales per share (Unadj.) | Rs | 21.0 | 25.2 | 21.4 | 30.1 | 67.6 | |
Earnings per share (Unadj.) | Rs | -6.8 | -2.3 | -21.8 | -3.5 | 13.4 | |
Diluted earnings per share | Rs | -5.7 | -1.9 | -18.9 | -3.0 | 11.6 | |
Cash flow per share (Unadj.) | Rs | -2.7 | 0.3 | -19.0 | -0.6 | 19.4 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 17.3 | 15.0 | -5.0 | -9.0 | 4.6 | |
Adj. book value per share | Rs | 14.7 | 12.8 | -4.3 | -7.8 | 4.0 | |
Shares outstanding (eoy) | m | 28.14 | 28.14 | 28.69 | 28.69 | 28.69 | |
Price / Sales ratio | x | 2.9 | 1.5 | 1.0 | 0.8 | 2.2 | |
Avg P/E ratio | x | -8.9 | -16.3 | -1.0 | -6.9 | 10.9 | |
P/CF ratio (eoy) | x | -22.0 | 107.4 | -1.2 | -39.3 | 7.5 | |
Price / Book Value ratio | x | 3.5 | 2.4 | -4.5 | -2.7 | 31.4 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 1,696 | 1,033 | 645 | 694 | 4,189 | |
Total wages/salary | Rs m | 170 | 147 | 139 | 146 | 181 |
LYKA LABS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 590 | 708 | 615 | 863 | 1,941 | |
Other income | Rs m | 21 | 21 | 31 | 16 | 21 | |
Total revenues | Rs m | 611 | 729 | 646 | 878 | 1,962 | |
Gross profit | Rs m | -13 | -30 | -369 | 186 | 946 | |
Depreciation | Rs m | 113 | 73 | 80 | 83 | 173 | |
Interest | Rs m | 96 | 72 | 201 | 259 | 201 | |
Profit before tax | Rs m | -200 | -154 | -619 | -141 | 592 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | -10 | -91 | 7 | -41 | 208 | |
Profit after tax | Rs m | -190 | -64 | -626 | -101 | 384 | |
Gross profit margin | % | -2.2 | -4.3 | -60.0 | 21.5 | 48.8 | |
Effective tax rate | % | 5.2 | 58.8 | -1.2 | 28.7 | 35.1 | |
Net profit margin | % | -32.2 | -9.0 | -101.8 | -11.7 | 19.8 |
LYKA LABS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 491 | 351 | 359 | 291 | 522 | |
Current liabilities | Rs m | 1,671 | 848 | 663 | 499 | 994 | |
Net working cap to sales | % | -200.1 | -70.2 | -49.5 | -24.1 | -24.3 | |
Current ratio | x | 0.3 | 0.4 | 0.5 | 0.6 | 0.5 | |
Inventory Days | Days | 199 | 149 | 116 | 87 | 41 | |
Debtors Days | Days | 1,268 | 754 | 477 | 367 | 347 | |
Net fixed assets | Rs m | 1,762 | 1,677 | 1,520 | 1,446 | 1,334 | |
Share capital | Rs m | 281 | 281 | 287 | 287 | 287 | |
"Free" reserves | Rs m | 206 | 141 | -430 | -545 | -154 | |
Net worth | Rs m | 487 | 423 | -143 | -258 | 133 | |
Long term debt | Rs m | 49 | 793 | 1,261 | 1,514 | 625 | |
Total assets | Rs m | 2,252 | 2,029 | 1,879 | 1,737 | 1,856 | |
Interest coverage | x | -1.1 | -1.2 | -2.1 | 0.5 | 3.9 | |
Debt to equity ratio | x | 0.1 | 1.9 | -8.8 | -5.9 | 4.7 | |
Sales to assets ratio | x | 0.3 | 0.3 | 0.3 | 0.5 | 1.0 | |
Return on assets | % | -4.2 | 0.4 | -22.6 | 9.1 | 31.6 | |
Return on equity | % | -39.0 | -15.0 | 436.5 | 39.1 | 288.2 | |
Return on capital | % | -19.5 | -6.8 | -37.4 | 9.4 | 104.7 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
LYKA LABS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 109 | 267 | 53 | 88 | 792 | |
From Investments | Rs m | -32 | -40 | -1 | -2 | -62 | |
From Financial Activity | Rs m | -104 | -234 | 34 | -118 | -632 | |
Net Cashflow | Rs m | -27 | -7 | 86 | -31 | 99 |
Share Holding
Shareholding as on Mar 2023
|
Company Information
|
CHM: Kunal N Gandhi | COMP SEC: Kishore P Shah | YEAR OF INC: 1976 | BSE CODE: 500259 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: AUROBINDO PHARMA CIPLA PIRAMAL ENTERPRISES LUPIN DR. REDDYS LAB
Compare LYKA LABS With: AUROBINDO PHARMA CIPLA PIRAMAL ENTERPRISES LUPIN DR. REDDYS LAB
After opening the day flat, Indian share markets picked up pace as session progressed and ended the day higher.